Your account is not claimed yet. You can sign up with ORCID to claim your account.

Francesca Colombo

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2017-2023
Publications (10 Years): 11

Top Venues

Scientific reports

Cancers

BioEssays : news and reviews in molecular, cellular and developmental biology

Cancer science

Fondazione IRCCS Istituto Nazionale dei Tumori

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Fondazione IRCCS Istituto Nazionale dei Tumori

Italy

Biotecnologo :: Preventive and Predictive Medicine

Publications

Tommaso A Dragani, Thomas Muley, Marc A Schneider, Sonja Kobinger, Martin Eichhorn, Hauke Winter, Hans Hoffmann, Mark Kriegsmann, Sara Noci, Matteo Incarbone, Davide Tosi, Sara Franzi, Francesca Colombo
Lung Adenocarcinoma Diagnosed at a Younger Age Is Associated with Advanced Stage, Female Sex, and Ever-Smoker Status, in Patients Treated with Lung Resection. Cancers 15 (8) (2023)
Tommaso A Dragani, Thomas Muley, Marc A Schneider, Sonja Kobinger, Martin Eichhorn, Hauke Winter, Hans Hoffmann, Mark Kriegsmann, Sara Noci, Matteo Incarbone, Davide Tosi, Sara Franzi, Francesca Colombo
Lung Adenocarcinoma Diagnosed at a Younger Age Is Associated with Advanced Stage, Female Sex, and Ever-Smoker Status, in Patients Treated with Lung Resection. Cancers 15 (8) (2023)
Francesca Minnai, Sara Noci, Nunzia Mangano, Loris De Cecco, Cristina Meazza, Monica Terenziani, Maura Massimino, Francesca Colombo
A pilot exome sequencing study suggests that germline variants influence methotrexate-induced toxicities in pediatric patients with localized osteosarcoma. Pediatric blood & cancer (2023)
Francesca Minnai, Gianluca De Bellis, Tommaso Antonio Dragani, Francesca Colombo
COVID-19 mortality in Italy varies by patient age, sex and pandemic wave. Scientific reports 12 (1) (2022)
Francesca Minnai, Sara Noci, Marco Chierici, Chiara Elisabetta Cotroneo, Barbara Bartolini, Matteo Incarbone, Davide Tosi, Giovanni Mattioni, Giuseppe Jurman, Tommaso Antonio Dragani, Francesca Colombo
Genetic predisposition to lung adenocarcinoma outcome is a feature already present in patients' noninvolved lung tissue. Cancer science (2022)
Anthony Onoja, Nicola Picchiotti, Chiara Fallerini, Margherita Baldassarri, Francesca Fava, null null, Francesca Colombo, Francesca Chiaromonte, Alessandra Renieri, Simone Furini, Francesco Raimondi
An explainable model of host genetic interactions linked to COVID-19 severity. Communications biology 5 (1) (2022)
Tommaso A Dragani, Valerie Matarese, Francesca Colombo
Biomarkers for Early Cancer Diagnosis: Prospects for Success through the Lens of Tumor Genetics. BioEssays : news and reviews in molecular, cellular and developmental biology 42 (4) (2020)
Francesca Colombo, Giulia Pintarelli, Antonella Galvan, Sara Noci, Oscar Corli, Frank Skorpen, Pål Klepstad, Stein Kaasa, Alessandra Pigni, Cinzia Brunelli, Anna Roberto, Rocco Giovanni Piazza, Alessandra Pirola, Carlo B Gambacorti-Passerini, Augusto Tommaso Caraceni
Identification of genetic polymorphisms modulating nausea and vomiting in two series of opioid-treated cancer patients. Scientific reports 10 (1) (2020)
Giulia Pintarelli, Sara Noci, Davide Maspero, Angela Pettinicchio, Matteo Dugo, Loris De Cecco, Matteo Incarbone, Davide Tosi, Luigi Santambrogio, Tommaso Antonio Dragani, Francesca Colombo
Cigarette smoke alters the transcriptome of non-involved lung tissue in lung adenocarcinoma patients. Scientific reports 9 (1) (2019)
Giulia Pintarelli, Antonella Galvan, Paolo Pozzi, Sara Noci, Giovanna Pasetti, Francesca Sala, Ugo Pastorino, Roberto Boffi, Francesca Colombo
Pharmacogenetic study of seven polymorphisms in three nicotinic acetylcholine receptor subunits in smoking-cessation therapies. Scientific reports 7 (1) (2017)
Andrea Necchi, Giulia Pintarelli, Daniele Raggi, Patrizia Giannatempo, Francesca Colombo
Association of an aurora kinase a (AURKA) gene polymorphism with progression-free survival in patients with advanced urothelial carcinoma treated with the selective aurora kinase a inhibitor alisertib. Investigational new drugs 35 (4) (2017)

Francesca Colombo.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Francesca Colombo